Erstellt von fchar99
Alnylam Pharmace. diskutieren
Alnylam Pharmace.
WKN: A0CBCK / Symbol: ALNY / Name: Alnylam Pharms / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /
253,10 €
-0,12 %
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $510.00 price target on the stock.
Ratings data for ALNY provided by MarketBeat
Alnylam Pharmaceuticals (ALNY) had its "buy" rating reaffirmed by HC Wainwright. They now have a $510.00 price target on the stock.
Ratings data for ALNY provided by MarketBeat
Alnylam Pharmaceuticals (ALNY) had its "buy" rating reaffirmed by Chardan Capital. They now have a $425.00 price target on the stock.
Ratings data for ALNY provided by MarketBeat
Alnylam Pharmaceuticals (ALNY) had its price target lowered by Truist Financial Corporation from $515.00 to $505.00. They now have a "buy" rating on the stock.
Ratings data for ALNY provided by MarketBeat
Alnylam Pharmaceuticals (ALNY) is now covered by Citigroup Inc.. They set a "buy" rating and a $380.00 price target on the stock.
Ratings data for ALNY provided by MarketBeat
Alnylam Pharmaceuticals (ALNY) had its "buy" rating reaffirmed by HC Wainwright. They now have a $510.00 price target on the stock.
Ratings data for ALNY provided by MarketBeat
Alnylam Pharmaceuticals (ALNY) was downgraded by Wall Street Zen from "strong-buy" to "buy".
Ratings data for ALNY provided by MarketBeat
Alnylam Pharmaceuticals (ALNY) had its price target lowered by HC Wainwright from $510.00 to $470.00. They now have a "buy" rating on the stock.
Ratings data for ALNY provided by MarketBeat
Alnylam Pharmaceuticals (ALNY) was downgraded by Wall Street Zen from "strong-buy" to "buy".
Ratings data for ALNY provided by MarketBeat
Alnylam Pharmaceuticals (ALNY) had its price target raised by HC Wainwright from $470.00 to $485.00. They now have a "buy" rating on the stock.
Ratings data for ALNY provided by MarketBeat
Alnylam Pharmaceuticals (ALNY) had its price target lowered by Bank of America Corporation from $460.00 to $410.00. They now have a "buy" rating on the stock.
Ratings data for ALNY provided by MarketBeat
Alnylam Pharmaceuticals (ALNY) had its price target lowered by JPMorgan Chase & Co. from $420.00 to $400.00. They now have an "overweight" rating on the stock.
Ratings data for ALNY provided by MarketBeat
Neueste Beiträge
BMO_Capital_Markets in Visa Inc. A diskutieren